Mustang Bio Inc.
MBIO | NASDAQ
$0.55
+$0.01 (+1.91%)
At close: Sep 21, 2026, 4:00 PM ET
$0.55
$0 (0.00%)
Pre-market:
Sep 22, 2026, 7:47 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -2.52 | -3.44 | -11.25 | -26.33 | -109.21 | -166.01 |
PEG Ratio | 0.03 | 0.06 | 0.24 | 20.01 | 3.28 | 11.35 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
PB Ratio | 0.51 | -14 | 4.72K | 44.14 | 64.90 | 101.11 |
P/FCF Ratio | -0.91 | -4.75 | -11.71 | -29.97 | -123.57 | -238.49 |
P/OCF Ratio | -0.91 | -4.75 | -11.74 | -31.39 | -135.92 | -266.69 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Debt / Equity Ratio | n/a | -0.23 | 20.31 | 0.68 | 0.02 | 0.02 |
Quick Ratio | 2.22 | 0.68 | 0.74 | 5.22 | 10.33 | 10.46 |
Current Ratio | 2.22 | 0.68 | 0.74 | 5.22 | 10.33 | 10.46 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a |
Interest Coverage | n/a | 3.25K | -38.60 | -22.67 | -4.45K | -14.50 |
Return on Equity | -20.16% | 406.71% | -41.95K% | -167.54% | -59.05% | -60.97% |
Return on Assets | -10.92% | -169.23% | -290.85% | -83.88% | -53.02% | -54.61% |
Return on Invested Capital | -25.13% | 571% | -1.75K% | -97.73% | -58.17% | -56.43% |
Dividend Yield | n/a | 1.13% | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | -3.88% | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | -5.57% | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove MBIO